JOINN’s ophthalmology laboratories were established in 2012 and GLP compliant studies are performed by a 35+ person scientific team. The JOINN ocular team has completed over 500 studies and generated data for 30 IND submissions. The facility is AAALAC accredited, inspected by the US FDA, PMDA and MFDS for GLP services and certified by NMPA, OECD and CNAS/ILAC-MRA.
JOINN Laboratories have deep expertise in ocular disease models and efficacy, tolerance and PK studies for ocular therapies. The JOINN team has supported early discovery through phase I clinical studies including GLP toxicology programs. The team combines comprehensive dosing techniques and specialized surgical procedures with state-of-the-art ocular imaging technology, tissue collection and histopathology analysis.
JOINN offers a broad array of ocular disease models including:
